3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
21
Phase 2
8
Phase 4
2
Phase 3
2
Phase 1/2
2
Phase 1
2
Phase EARLY_PHASE1
1
Status
Unknown
1
Recruiting
1
Sponsor Class
OTHER
2
Study Type
Interventional
2
Sponsor
Cancer Type
Thoracic
1
Other
1
Gynecologic
1
Conditions
Uterine Cervical Neoplasms
1
Sexual Dysfunction, Physiological
1
Lung Neoplasms
1
Carcinoma, Non-Small-Cell Lung
1
Interventions
Dexamethasone
49
Metformin
47
Cyclophosphamide
42
Saline Solution
38
Cytarabine
34
Sodium Chloride
32
Bupivacaine
31
Vincristine
27
Cisplatin
26
Propofol
25
Methotrexate
25
Letrozole
24
Fluorouracil
24
Dexmedetomidine
24
Doxorubicin
23
Fentanyl
22
Carboplatin
22
Etoposide
19
Rituximab
18
Morphine
18
Bevacizumab
18
Acetaminophen
18
Lidocaine
17
Granulocyte Colony-Stimulating Factor
17
Prednisone
16
Mercaptopurine
16
Docetaxel
16
Clomiphene
16
Sevoflurane
15
Ropivacaine
15
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Phase 4
×
OTHER
×
Quality of Life
×
Clear all
NCT06646471
2026-04-29
PROMETHEE
Groupe Francais De Pneumo-Cancerologie
Phase 4
Recruiting
500 enrolled
NCT06031493
2024-02-28
PROVIDENCE
Hospital Clinic of Barcelona
Phase 4
Unknown
122 enrolled